TESS Research Foundation 2017 Grant Program
TESS Research Foundation’s mission is to find the best
treatment options and ultimately a cure for SLC13A5 Deficiency,
a citrate transporter disorder accompanied by a severe form of
epilepsy beginning in infancy. The TESS Research Foundation
Grant Program funds research related to the epileptic
encephalopathies caused by mutations in the SLC13A5 gene.